#	Pagina
attuale pagina	/open-h2020/projects/198798/index.html

Opendata, web and dolomites

EAVI2020 SIGNED

European AIDS Vaccine Initiative 2020

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

EAVI2020 project word cloud

Explore the words cloud of the EAVI2020 project. It provides you a very rough idea of what is the project "EAVI2020" about.

eliminate 35 eradication complement acknowledged aids canadian infections therapeutic rapid forces ultimately platform global emphasis modalities risk candidates models eavi pool technologies discovery countries australian clinical public homologous infection course heterologous vectors shift progression experimental protective prime adjuvants join schedules continues immunogens boost overcome eavi2020 vaccine innovative collaborators immunization expertise hiv placed impacting host curve agreed human designed pandemic preventive refine international chance reduce bottleneck gender small rate medicine mitigate strategies stage iterative prediction clinic animal people select diverse protecting spread em million groups disease genetics highest gt biotechs despite competitive responsible viral

Project "EAVI2020" data sheet

The following table provides information about the project.

Coordinator	IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE Organization address address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD city: LONDON postcode: SW7 2AZ website: http://www.imperial.ac.uk/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	United Kingdom [UK]
Project website	http://www.eavi2020.eu/
Total cost	24˙088˙765 €
EC max contribution	22˙948˙022 € (95%)
Programme	1. H2020-EU.3.1.2. (Preventing disease)
Code Call	H2020-PHC-2015-single-stage_RTD
Funding Scheme	RIA
Starting year	2015
Duration (year-month-day)	from 2015-11-01 to 2020-10-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE Organization address address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD city: LONDON postcode: SW7 2AZ website: http://www.imperial.ac.uk/ contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	coordinator	6˙118˙355.00
2	POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH Organization address address: DONAUSTRASSE 99 city: KLOSTERNEUBURG postcode: 3400 website: www.polymun.com contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (KLOSTERNEUBURG)	participant	3˙449˙000.00
3	THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD Organization address address: WELLINGTON SQUARE UNIVERSITY OFFICES city: OXFORD postcode: OX1 2JD website: www.ox.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (OXFORD)	participant	2˙300˙415.00
4	FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA Organization address address: CARRETERA DE CANYET city: BARCELONA postcode: 8916 website: www.irsicaixa.es contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	1˙998˙031.00
5	COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES Organization address address: RUE LEBLANC 25 city: PARIS 15 postcode: 75015 website: www.cea.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS 15)	participant	1˙390˙635.00
6	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE Organization address address: RUE DE TOLBIAC 101 city: PARIS postcode: 75654 website: www.inserm.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PARIS)	participant	1˙140˙062.00
7	KAROLINSKA INSTITUTET KAROLINSKA INSTITUTET Organization address address: Nobels Vag 5 city: STOCKHOLM postcode: 17177 website: www.ki.se contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (STOCKHOLM)	participant	895˙561.00
8	OSPEDALE SAN RAFFAELE SRL OSPEDALE SAN RAFFAELE SRL Organization address address: VIA OLGETTINA 60 city: MILANO postcode: 20132 website: www.hsr.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (MILANO)	participant	669˙938.00
9	FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA Organization address address: CARRER ROSSELLO 149 city: BARCELONA postcode: 8036 website: www.fundacioclinic.org contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (BARCELONA)	participant	633˙185.00
10	INTERNATIONAL AIDS VACCINE INITIATIVE INC INTERNATIONAL AIDS VACCINE INITIATIVE INC Organization address address: 125 BROAD STREET, 9TH FLOOR city: NEW YORK postcode: 10004 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	US (NEW YORK)	participant	626˙000.00
11	UNIVERSITE GRENOBLE ALPES UNIVERSITE GRENOBLE ALPES Organization address address: 621, AVENUE CENTRALE city: SAINT MARTIN D'HERES postcode: 38401 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (SAINT MARTIN D'HERES)	participant	612˙907.00
12	ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM Organization address address: MEIBERGDREEF 15 city: AMSTERDAM postcode: 1105AZ website: www.amc.nl contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (AMSTERDAM)	participant	571˙500.00
13	UNIVERSITATSKLINIKUM ERLANGEN UNIVERSITATSKLINIKUM ERLANGEN Organization address address: MAXIMILIANSPLATZ 2 city: ERLANGEN postcode: 91054 website: www.uk-erlangen.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (ERLANGEN)	participant	564˙021.00
14	INSTITUTO DE SALUD CARLOS III INSTITUTO DE SALUD CARLOS III Organization address address: MONFORTE DE LEMOS 5 city: MADRID postcode: 28029 website: http://www.isciii.es contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	ES (MADRID)	participant	403˙828.00
15	ISTITUTO SUPERIORE DI SANITA ISTITUTO SUPERIORE DI SANITA Organization address address: Viale Regina Elena 299 city: ROMA postcode: 161 website: http://www.iss.it contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (ROMA)	participant	389˙700.00
16	BIONTECH RNA PHARMACEUTICALS GMBH BIONTECH RNA PHARMACEUTICALS GMBH Organization address address: AN DER GOLDGRUBE 12 city: MAINZ postcode: 55131 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (MAINZ)	participant	371˙375.00
17	NEMZETI ELELMISZERLANC-BIZTONSAGI HIVATAL NEMZETI ELELMISZERLANC-BIZTONSAGI HIVATAL Organization address address: KELETI KAROLY UTCA 24 city: BUDAPEST postcode: 1024 website: www.aogyti.gov.hu contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	HU (BUDAPEST)	participant	211˙298.00
18	UNIVERSITY OF SOUTHAMPTON UNIVERSITY OF SOUTHAMPTON Organization address address: Highfield city: SOUTHAMPTON postcode: SO17 1BJ website: http://www.southampton.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (SOUTHAMPTON)	participant	210˙343.00
19	LUDWIG BOLTZMANN GESELLSCHAFT GMBH LUDWIG BOLTZMANN GESELLSCHAFT GMBH Organization address address: NUSSDORFER STRASSE 64 6 STOCK city: WIEN postcode: 1090 website: www.lbg.ac.at contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AT (WIEN)	participant	201˙250.00
20	KING'S COLLEGE LONDON KING'S COLLEGE LONDON Organization address address: STRAND city: LONDON postcode: WC2R 2LS website: www.kcl.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	participant	190˙612.00
21	GENOME RESEARCH LIMITED GENOME RESEARCH LIMITED Organization address address: THE GIBBS BUILDING, EUSTON ROAD 215 city: LONDON postcode: NW1 2BE website: http://www.sanger.ac.uk contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (LONDON)	participant	0.00
22	STICHTING INTERNATIONAL AIDS VACCINE INITIATIVE THE NETHERLANDS STICHTING INTERNATIONAL AIDS VACCINE INITIATIVE THE NETHERLANDS Organization address address: VAN DIEMENSTRAAT 20, 200 UNIT 48 city: AMSTERDAM postcode: 1013 NH website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (AMSTERDAM)	participant	0.00
23	THE UNIVERSITY OF WESTERN ONTARIO THE UNIVERSITY OF WESTERN ONTARIO Organization address address: RICHMOND STREET NORD - SUITE 2 1151 city: ONTARIO -LONDON postcode: N6A 3K7 website: www.uwo.ca contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	CA (ONTARIO -LONDON)	participant	0.00
24	UNIVERSITE JOSEPH FOURIER GRENOBLE 1 UNIVERSITE JOSEPH FOURIER GRENOBLE 1 Organization address address: Avenue Centrale, Domaine Universitaire 621 city: GRENOBLE postcode: 38041 website: www.ujf-grenoble.fr contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (GRENOBLE)	participant	0.00
25	UNIVERSITY OF MELBOURNE UNIVERSITY OF MELBOURNE Organization address address: PARKVILLEOFFICE OF THE VICE CHANCELLOR city: MELBOURNE postcode: 3010 website: www.unimelb.edu.au contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AU (MELBOURNE)	participant	0.00
26	UNIVERSITY OF NEW SOUTH WALES UNIVERSITY OF NEW SOUTH WALES Organization address address: ANZAC PARADE city: SYDNEY postcode: 2052 website: http://www.unsw.edu.au contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	AU (SYDNEY)	participant	0.00

Map

Project objective

HIV-1 is responsible for a global pandemic of 35 million people, and continues to spread at a rate of >2 million new infections/year. It is widely acknowledged that a protective vaccine would be the most effective means to reduce HIV-1 spread and ultimately eliminate the pandemic, while a therapeutic vaccine may help mitigate the clinical course of disease and lead to strategies of viral eradication. However despite 30 years of research, we do not have a vaccine capable of protecting from HIV-1 infection or impacting on disease progression. This in part represents the challenge of identifying immunogens and vaccine modalities with reduced risk of failure in late stage development. To overcome this bottleneck some of the most competitive research groups in vaccine discovery from European public institutions and biotechs from 9 EU countries together with top Australian and Canadian groups and US collaborators, have agreed to join forces in EAVI, providing a pool of international expertise at the highest level. EAVI2020 will provide a platform for the discovery and selection of several new, diverse and novel preventive and/or therapeutic vaccine candidates for HIV/AIDS. Emphasis will be placed on early rapid, iterative, small Experimental medicine (EM) human vaccine studies to select and refine the best immunogens, adjuvants, vectors, homologous and heterologous prime–boost schedules, and determine the impact of host factors such as gender and genetics. Animal models will be used to complement human studies, and to select novel immunization technologies to be advanced to the clinic. To shift the “risk curve” in product development we will develop innovative risk prediction methods, specifically designed to reduce the risk associated with late stage preventive or therapeutic vaccine failure, increasing the chance of discovery of an effective vaccine.

Deliverables

List of deliverables.
EAVI2020 Website	Websites, patent fillings, videos etc.	2019-09-04 11:55:06
Marketing and Dissemination Kit	Other	2019-09-04 11:55:06

Take a look to the deliverables list in detail: detailed list of EAVI2020 deliverables.

Publications

List of publications.
year	authors and title	journal	last update
2019	Vincent Vieillard, BÃ©hazine CombadiÃ¨re, Roland Tubiana, Odile Launay, Gilles Pialoux, Laurent Cotte, Pierre-Marie Girard, Anne Simon, Yasmine Dudoit, Jacques Reynes, JÃ¼rgen Rockstroh, Felipe Garcia, Jose Gatell, Alain Devidas, Yazdan Yazdanpanah, Laurence Weiss, Gerd FÃ¤tkenheuer, Brigitte Autran, Delphine Joyeux, Shahin Gharakhanian, Patrice DebrÃ©, Christine Katlama HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial published pages: , ISSN: 2059-0105, DOI: 10.1038/s41541-019-0117-5	npj Vaccines 4/1	2020-01-27
2018	Carolina Beltran-Pavez, Carolina B. Ferreira, Alberto Merino-Mansilla, Amanda Fabra-Garcia, Maria Casadella, Marc Noguera-Julian, Roger Paredes, Alex Olvera, Isabel Haro, Christian Brander, Felipe Garcia, Jose M. Gatell, Eloisa Yuste, Victor Sanchez-Merino Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant published pages: e0208345, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0208345	PLOS ONE 13/12	2020-01-27
2019	Gemma E. Seabright, Katie J. Doores, Dennis R. Burton, Max Crispin Protein and Glycan Mimicry in HIV Vaccine Design published pages: 2223-2247, ISSN: 0022-2836, DOI: 10.1016/j.jmb.2019.04.016	Journal of Molecular Biology 431/12	2020-01-27
2019	Esther Broset, NarcÃs Saubi, NÃºria Guitart, Nacho Aguilo, Santiago Uranga, Athina KilpelÃ¤inen, Yoshiki Eto, TomÃ¡Å¡ Hanke, JesÃºs Gonzalo-Asensio, Carlos MartÃn, Joan Joseph-MunnÃ© MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice published pages: 253-264, ISSN: 2329-0501, DOI: 10.1016/j.omtm.2019.01.014	Molecular Therapy - Methods & Clinical Development 13	2020-01-27
2019	Marta Ruiz-Riol, Christian Brander Can we just kick-and-kill HIV: possible challenges posed by the epigenetically controlled interplay between HIV and host immunity published pages: 931-935, ISSN: 1750-743X, DOI: 10.2217/imt-2019-0092	Immunotherapy 11/11	2020-01-27
2019	Meng Yuan, Christopher A. Cottrell, Gabriel Ozorowski, Marit J. van Gils, Sonu Kumar, Nicholas C. Wu, Anita Sarkar, Jonathan L. Torres, Natalia de Val, Jeffrey Copps, John P. Moore, Rogier W. Sanders, Andrew B. Ward, Ian A. Wilson Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies published pages: 873-883.e5, ISSN: 1931-3128, DOI: 10.1016/j.chom.2019.04.011	Cell Host & Microbe 25/6	2020-01-27
2019	CombadiÃ¨re, Beaujean, Chaudesaigues, Vieillard Peptide-Based Vaccination for Antibody Responses Against HIV published pages: 105, ISSN: 2076-393X, DOI: 10.3390/vaccines7030105	Vaccines 7/3	2020-01-27
2019	NÃ©stor VÃ¡zquez Bernat, Martin Corcoran, Uta Hardt, Mateusz Kaduk, Ganesh E. Phad, Marcel Martin, Gunilla B. Karlsson Hedestam High-Quality Library Preparation for NGS-Based Immunoglobulin Germline Gene Inference and Repertoire Expression Analysis published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2019.00660	Frontiers in Immunology 10	2020-01-27
2019	Mitch Brinkkemper, Kwinten Sliepen Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies published pages: 76, ISSN: 2076-393X, DOI: 10.3390/vaccines7030076	Vaccines 7/3	2020-01-27
2019	Dirk Eggink, Ilja Bontjer, Steven W. de Taeye, Johannes P. M. Langedijk, Ben Berkhout, Rogier W. Sanders HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry published pages: 5736-5746, ISSN: 0021-9258, DOI: 10.1074/jbc.RA119.007360	Journal of Biological Chemistry 294/15	2020-01-27
2019	Yasunori Watanabe, Thomas A. Bowden, Ian A. Wilson, Max Crispin Exploitation of glycosylation in enveloped virus pathobiology published pages: 1480-1497, ISSN: 0304-4165, DOI: 10.1016/j.bbagen.2019.05.012	Biochimica et Biophysica Acta (BBA) - General Subjects 1863/10	2020-01-27
2019	Alba Torrents de la PeÃ±a, Kimmo Rantalainen, Christopher A. Cottrell, Joel D. Allen, Marit J. van Gils, Jonathan L. Torres, Max Crispin, Rogier W. Sanders, Andrew B. Ward Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics published pages: e1007920, ISSN: 1553-7374, DOI: 10.1371/journal.ppat.1007920	PLOS Pathogens 15/7	2020-01-27
2019	Athina KilpelÃ¤inen, NarcÃs Saubi, NÃºria Guitart, Nathifa Moyo, Edmund G. Wee, Krupa Ravi, TomÃ¡Å¡ Hanke, Joan Joseph Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2019.00923	Frontiers in Immunology 10	2020-01-27
2019	Kwinten Sliepen, Byung Woo Han, Ilja Bontjer, Petra Mooij, Fernando Garces, Anna-Janina Behrens, Kimmo Rantalainen, Sonu Kumar, Anita Sarkar, Philip J. M. Brouwer, Yuanzi Hua, Monica Tolazzi, Edith Schermer, Jonathan L. Torres, Gabriel Ozorowski, Patricia van der Woude, Alba Torrents de la PeÃ±a, MariÃ«lle J. van Breemen, Juan Miguel Camacho-SÃ¡nchez, Judith A. Burger, Max Medina-RamÃrez, Nuria G Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-019-10262-5	Nature Communications 10/1	2020-01-27
2019	Philip J. M. Brouwer, Aleksandar Antanasijevic, Zachary Berndsen, Anila Yasmeen, Brooke Fiala, Tom P. L. Bijl, Ilja Bontjer, Jacob B. Bale, William Sheffler, Joel D. Allen, Anna Schorcht, Judith A. Burger, Miguel Camacho, Daniel Ellis, Christopher A. Cottrell, Anna-Janina Behrens, Marco Catalano, IvÃ¡n del Moral-SÃ¡nchez, Thomas J. Ketas, Celia LaBranche, Marit J. van Gils, Kwinten Sliepen, Lance Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-019-12080-1	Nature Communications 10/1	2020-01-27
2019	Athina KilpelÃ¤inen, NarcÃs Saubi, NÃºria Guitart, Alex Olvera, TomÃ¡Å¡ Hanke, Christian Brander, Joan Joseph Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice published pages: 78, ISSN: 2076-393X, DOI: 10.3390/vaccines7030078	Vaccines 7/3	2020-01-27
2019	Rebecca HeÃŸ, Michael Storcksdieck genannt Bonsmann, Dennis Lapuente, Andre Maaske, Carsten Kirschning, JÃ¼rgen Ruland, Bernd Lepenies, Drew Hannaman, Matthias Tenbusch, Klaus Ãœberla Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination published pages: 153, ISSN: 1999-4915, DOI: 10.3390/v11020153	Viruses 11/2	2020-01-27
2019	Edmund G. Wee, Nathifa A. Moyo, Kevin O. Saunders, Celia LaBranche, Filippo Donati, Silvia Capucci, Robert Parks, Nicola Borthwick, Zara Hannoun, David C. Montefiori, Barton F. Haynes, TomÃ¡Å¡ Hanke Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1 published pages: 148-160, ISSN: 2329-0501, DOI: 10.1016/j.omtm.2019.06.003	Molecular Therapy - Methods & Clinical Development 14	2020-01-27
2018	Ester Lopez, Robin J. Shattock, Stephen J. Kent, Amy W. Chung The Multifaceted Nature of Immunoglobulin A and Its Complex Role in HIV published pages: 727-738, ISSN: 0889-2229, DOI: 10.1089/aid.2018.0099	AIDS Research and Human Retroviruses 34/9	2020-01-27
2018	Jenna Anderson, Thorunn A. Olafsdottir, Sven Kratochvil, Paul F. McKay, Malin Ã–stensson, Josefine Persson, Robin J. Shattock, Ali M. Harandi Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2018.00301	Frontiers in Immunology 9	2019-09-04
2017	S. Stenler, K. E. Lundin, L. Hansen, S. Petkov, N. Mozafari, M. Isaguliants, P. Blomberg, C. I. E. Smith, D. M. Goldenberg, C.-H. Chang, K. Ljungberg, J. Hinkula, B. Wahren Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses published pages: 2849-2858, ISSN: 2164-5515, DOI: 10.1080/21645515.2017.1338546	Human Vaccines & Immunotherapeutics 13/12	2019-09-04
2018	Alex Olvera, Javier P. Martinez, Maria CasadellÃ , Anuska Llano, MÃriam RosÃ¡s, Beatriz Mothe, Marta Ruiz-Riol, Gemma Arsequell, Gregorio Valencia, Marc Noguera-Julian, Roger Paredes, Andreas Meyerhans, Christian Brander Benzyl-2-Acetamido-2-Deoxy-Î±-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.02010	Frontiers in Immunology 8	2019-09-04
2017	Sven Kratochvil, Paul F. McKay, Amy W. Chung, Stephen J. Kent, Jill Gilmour, Robin J. Shattock Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.01883	Frontiers in Immunology 8	2019-09-04
2018	Yoann Aldon, Paul F. McKay, Joel Allen, Gabriel Ozorowski, RÃ©ka FelfÃ¶dinÃ© LÃ©vai, Monica Tolazzi, Paul Rogers, Linling He, Natalia de Val, Katalin FÃ¡biÃ¡n, Gabriella Scarlatti, Jiang Zhu, Andrew B. Ward, Max Crispin, Robin J. Shattock Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers published pages: 3324-3338.e5, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2018.08.051	Cell Reports 24/12	2019-09-04
2016	Karen P. Coss, Snezana Vasiljevic, Laura K. Pritchard, Stefanie A. Krumm, Molly Glaze, Sharon Madzorera, Penny L. Moore, Max Crispin, Katie J. Doores HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual published pages: 11132-11144, ISSN: 0022-538X, DOI: 10.1128/JVI.01542-16	Journal of Virology 90/24	2019-09-04
2018	Nuria GonzÃ¡lez, Krisha McKee, Rebecca M. Lynch, Ivelin S. Georgiev, Laura Jimenez, Eulalia Grau, EloÃsa Yuste, Peter D. Kwong, John R. Mascola, JosÃ© AlcamÃ Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors published pages: e0193773, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0193773	PLOS ONE 13/3	2019-09-04
2018	Max Crispin, Andrew B. Ward, Ian A. Wilson Structure and Immune Recognition of the HIV Glycan Shield published pages: 499-523, ISSN: 1936-122X, DOI: 10.1146/annurev-biophys-060414-034156	Annual Review of Biophysics 47/1	2019-09-04
2017	Sven Kratochvil, Paul F. McKay, Jakub T. Kopycinski, Cynthia Bishop, Peter John Hayes, Luke Muir, Christopher L. Pinder, Deniz Cizmeci, Deborah King, Yoann Aldon, Bruce D. Wines, P. Mark Hogarth, Amy W. Chung, Stephen J. Kent, Kathrin Held, Christof Geldmacher, Len Dally, Nelson S. Santos, Tom Cole, Jill Gilmour, Sarah Fidler, Robin J. Shattock A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.00595	Frontiers in Immunology 8	2019-09-04
2016	V. Sanchez-Merino, A. Fabra-Garcia, N. Gonzalez, D. Nicolas, A. Merino-Mansilla, C. Manzardo, J. Ambrosioni, A. Schultz, A. Meyerhans, J. R. Mascola, J. M. Gatell, J. Alcami, J. M. Miro, E. Yuste Detection of Broadly Neutralizing Activity within the First Months of HIV-1 Infection published pages: 5231-5245, ISSN: 0022-538X, DOI: 10.1128/JVI.00049-16	Journal of Virology 90/11	2019-09-04
2017	Vladimir Temchura, Klaus Ãœberla Intrastructural help published pages: 272-277, ISSN: 1746-630X, DOI: 10.1097/COH.0000000000000358	Current Opinion in HIV and AIDS 12/3	2019-09-04
2017	Anna-Janina Behrens, Max Crispin Structural principles controlling HIV envelope glycosylation published pages: 125-133, ISSN: 0959-440X, DOI: 10.1016/j.sbi.2017.03.008	Current Opinion in Structural Biology 44	2019-09-04
2018	Hassan Elsayed, Ghulam Nabi, William J. McKinstry, Keith K. Khoo, Johnson Mak, Andres M. Salazar, Matthias Tenbusch, Vladimir Temchura, Klaus Ãœberla Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines published pages: , ISSN: 0022-538X, DOI: 10.1128/JVI.00141-18	Journal of Virology 92/14	2019-09-04
2017	J Hinkula, S Petkov, K Ljungberg, D HallengÃ¤rd, A BrÃ¥ve, M Isaguliants, T Falkeborn, S Sharma, V Liakina, M Robb, M Eller, B Moss, G Biberfeld, E SandstrÃ¶m, C Nilsson, K Markland, P Blomberg, B Wahren HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV published pages: e00339, ISSN: 2405-8440, DOI: 10.1016/j.heliyon.2017.e00339	Heliyon 3/6	2019-09-04
2017	Anna-Janina Behrens, Weston B Struwe, Max Crispin Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1 published pages: 881-890, ISSN: 1478-9450, DOI: 10.1080/14789450.2017.1376658	Expert Review of Proteomics 14/10	2019-09-04
2019	Nathifa Moyo, Annette B. Vogel, SÃ¸ren Buus, Stephanie Erbar, Edmund G. Wee, Ugur Sahin, TomÃ¡Å¡ Hanke Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA published pages: 32-46, ISSN: 2329-0501, DOI: 10.1016/j.omtm.2018.10.010	Molecular Therapy - Methods & Clinical Development 12	2019-09-04
2017	Christopher L. Pinder, Sven Kratochvil, Deniz Cizmeci, Luke Muir, Yanping Guo, Robin J. Shattock, Paul F. McKay Isolation and Characterization of Antigen-Specific Plasmablasts Using a Novel Flow Cytometryâ€“Based Ig Capture Assay published pages: 4180-4188, ISSN: 0022-1767, DOI: 10.4049/jimmunol.1701253	The Journal of Immunology 199/12	2019-09-04
2018	Hannah Mary Cheeseman, Suzanne Day, Leon Robert McFarlane, Sue Fleck, Aleisha Miller, Tom Cole, Nelson Sousa-Santos, Alethea Cope, Deniz Cizmeci, Monica Tolazzi, Edith Hwekwete, Drew Hannaman, Sven Kratochvil, Paul Francis McKay, Amy W. Chung, Stephen J. Kent, Adrian Cook, Gabriella Scarlatti, Sonya Abraham, Behazine Combadiere, Sheena McCormack, David John Lewis, Robin John Shattock Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine published pages: 1011-1028, ISSN: 1043-0342, DOI: 10.1089/hum.2018.075	Human Gene Therapy 29/9	2019-09-04
2017	Edmund G. Wee, Beatrice Ondondo, Peter Berglund, Jacob Archer, Andrew J. McMichael, David Baltimore, Jan H. ter Meulen, TomÃ¡Å¡ Hanke HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells published pages: 494-503, ISSN: 1525-0016, DOI: 10.1016/j.ymthe.2016.12.004	Molecular Therapy 25/2	2019-09-04
2017	Olivier Lucar, Bin Su, ValÃ©rie Potard, Assia Samri, Brigitte Autran, Christiane Moog, Patrice DebrÃ©, Vincent Vieillard Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status published pages: 122-132, ISSN: 2352-3964, DOI: 10.1016/j.ebiom.2017.07.007	EBioMedicine 22	2019-09-04
2018	Torben Schiffner, Jesper Pallesen, Rebecca A. Russell, Jonathan Dodd, Natalia de Val, Celia C. LaBranche, David Montefiori, Georgia D. Tomaras, Xiaoying Shen, Scarlett L. Harris, Amin E. Moghaddam, Oleksandr Kalyuzhniy, Rogier W. Sanders, Laura E. McCoy, John P. Moore, Andrew B. Ward, Quentin J. Sattentau Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins published pages: e1006986, ISSN: 1553-7374, DOI: 10.1371/journal.ppat.1006986	PLOS Pathogens 14/5	2019-09-04
2017	Silvia Capucci, Edmund G. Wee, Torben Schiffner, Celia C. LaBranche, Nicola Borthwick, Albert Cupo, Jonathan Dodd, Hansi Dean, Quentin Sattentau, David Montefiori, Per J. Klasse, Rogier W. Sanders, John P. Moore, TomÃ¡Å¡ Hanke HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers published pages: e0181886, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0181886	PLOS ONE 12/8	2019-09-04
2017	Aakash Mahant, NarcÃs Saubi, Yoshiki Eto, NÃºria Guitart, Josep M Âª Gatell, TomÃ¡Å¡ Hanke, Joan Joseph Preclinical Development of BCG.HIVA 2auxo.int , Harboring an Integrative Expression Vector, for a HIV-TB Pediatric vaccine. Enhancement of Stability and Specific HIV-1 T-cell Immunity published pages: 00-00, ISSN: 2164-5515, DOI: 10.1080/21645515.2017.1316911	Human Vaccines & Immunotherapeutics	2019-09-04
2017	Max Medina-RamÃrez, Rogier W. Sanders, Quentin J. Sattentau Stabilized HIV-1 envelope glycoprotein trimers for vaccine use published pages: 241-249, ISSN: 1746-630X, DOI: 10.1097/COH.0000000000000363	Current Opinion in HIV and AIDS 12/3	2019-09-04
2017	Martina Soldemo, Gunilla B. Karlsson Hedestam Env-Specific Antibodies in Chronic Infection versus in Vaccination published pages: , ISSN: 1664-3224, DOI: 10.3389/fimmu.2017.01057	Frontiers in Immunology 8	2019-09-04
2017	Rogier W. Sanders, John P. Moore Native-like Env trimers as a platform for HIV-1 vaccine design published pages: 161-182, ISSN: 0105-2896, DOI: 10.1111/imr.12481	Immunological Reviews 275/1	2019-09-04
2017	M. Ruiz-Riol, D. Berdnik, A. Llano, B. Mothe, C. GÃ¡lvez, S. PÃ©rez-Ãlvarez, B. Oriol-Tordera, A. Olvera, S. Silva-Arrieta, M. Meulbroek, F. Pujol, J. Coll, J. Martinez-Picado, C. Ganoza, J. Sanchez, G. GÃ³mez, T. Wyss-Coray, C. Brander Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control published pages: e00441-17, ISSN: 0022-538X, DOI: 10.1128/JVI.00441-17	Journal of Virology 91/16	2019-09-04
2016	Marit J. van Gils, Tom L. G. M. van den Kerkhof, Gabriel Ozorowski, Christopher A. Cottrell, Devin Sok, Matthias Pauthner, Jesper Pallesen, Natalia de Val, Anila Yasmeen, Steven W. de Taeye, Anna Schorcht, Stephanie Gumbs, Inez Johanna, Karen Saye-Francisco, Chi-Hui Liang, Elise Landais, Xiaoyan Nie, Laura K. Pritchard, Max Crispin, Garnett Kelsoe, Ian A. Wilson, Hanneke Schuitemaker, Per Johan Klasse, John P. Moore, Dennis R. Burton, Andrew B. Ward, Rogier W. Sanders An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability published pages: 16199, ISSN: 2058-5276, DOI: 10.1038/nmicrobiol.2016.199	Nature Microbiology 2	2019-09-04
2017	Max Medina-RamÃrez, Fernando Garces, Amelia Escolano, Patrick Skog, Steven W. de Taeye, Ivan Del Moral-Sanchez, Andrew T. McGuire, Anila Yasmeen, Anna-Janina Behrens, Gabriel Ozorowski, Tom L.G.M. van den Kerkhof, Natalia T. Freund, Pia Dosenovic, Yuanzi Hua, Alexander D. Gitlin, Albert Cupo, Patricia van der Woude, Michael Golabek, Kwinten Sliepen, Tanya Blane, Neeltje Kootstra, MariÃ«lle J. van Breemen, Laura K. Pritchard, Robyn L. Stanfield, Max Crispin, Andrew B. Ward, Leonidas Stamatatos, Per Johan Klasse, John P. Moore, David Nemazee, Michel C. Nussenzweig, Ian A. Wilson, Rogier W. Sanders Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo published pages: 2573-2590, ISSN: 0022-1007, DOI: 10.1084/jem.20161160	The Journal of Experimental Medicine 214/9	2019-09-04
2017	Nicola Borthwick, Zhansong Lin, Tomohiro Akahoshi, Anuska Llano, Sandra Silva-Arrieta, Tina Ahmed, Lucy Dorrell, Christian Brander, Hayato Murakoshi, Masafumi Takiguchi, TomÃ¡Å¡ Hanke Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines published pages: e0176418, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0176418	PLOS ONE 12/4	2019-09-04

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EAVI2020" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EAVI2020" are provided by the European Opendata Portal: CORDIS opendata.